Gene therapy potential for genetic disorders of surfactant dysfunction

AL Cooney, JA Wambach, PL Sinn… - Frontiers in genome …, 2022 - frontiersin.org
Pulmonary surfactant is critically important to prevent atelectasis by lowering the surface
tension of the alveolar lining liquid. While respiratory distress syndrome (RDS) is common in …

Alveolar dynamics and beyond–the importance of surfactant protein C and cholesterol in lung homeostasis and fibrosis

K Sehlmeyer, J Ruwisch, N Roldan… - Frontiers in …, 2020 - frontiersin.org
Surfactant protein C (SP-C) is an important player in enhancing the interfacial adsorption of
lung surfactant lipid films to the alveolar air-liquid interface. Doing so, surface tension drops …

Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism

WB Eldridge, Q Zhang, A Faro, SC Sweet… - The Journal of …, 2017 - Elsevier
Objective To compare outcomes of infants and children who underwent lung transplantation
for genetic disorders of surfactant metabolism (SFTPB, SFTPC, ABCA3, and NKX2-1) over 2 …

Gene therapeutics for surfactant dysfunction disorders: targeting the alveolar type 2 epithelial cell

S Sitaraman, KD Alysandratos, JA Wambach… - Human Gene …, 2022 - liebertpub.com
Genetic disorders of surfactant dysfunction result in significant morbidity and mortality,
among infants, children, and adults. Available medical interventions are limited, nonspecific …

Update on diffuse lung disease in children

TJ Vece, LR Young - Chest, 2016 - Elsevier
Diffuse lung diseases in children, also called children's interstitial lung disease, are a
diverse group of rare disorders that cause disturbances of gas exchange in the lungs …

Descriptive and Functional Genomics in Neonatal Respiratory Distress Syndrome: From Lung Development to Targeted Therapies

M Anciuc-Crauciuc, MC Cucerea, F Tripon… - International Journal of …, 2024 - mdpi.com
In this up-to-date study, we first aimed to highlight the genetic and non-genetic factors
associated with respiratory distress syndrome (RDS) while also focusing on the genomic …

Ground glass and fibrotic change in children with surfactant protein C dysfunction mutations

EM DeBoer, DR Liptzin, SM Humphries… - Pediatric …, 2021 - Wiley Online Library
Introduction Therapeutics exist to treat fibrotic lung disease in adults, but these have not
been investigated in children. Defining biomarkers for pediatric fibrotic lung disease in …

A novel surfactant protein C gene mutation associated with progressive respiratory failure in infancy

MKS Litao, D Hayes Jr, S Chiwane… - Pediatric …, 2017 - Wiley Online Library
Summary Mutations of the Surfactant Protein C (SPC) gene (SFTPC) have been associated
with childhood interstitial lung disease (chILD) with variable age of onset, severity of lung …

Contemporary and emerging technologies for research in children's rare and interstitial lung disease

R Li, N Sone, S Gotoh, X Sun… - Pediatric …, 2024 - Wiley Online Library
Although recent decades have seen the identification, classification and discovery of the
genetic basis of many children's interstitial and rare lung disease (chILD) disorders, detailed …

Systematic review of drug effects in humans and models with surfactant-processing disease

D Klay, TW Hoffman, AM Harmsze… - European …, 2018 - Eur Respiratory Soc
Fibrotic interstitial pneumonias are a group of rare diseases characterised by distortion of
lung interstitium. Patients with mutations in surfactant-processing genes, such as surfactant …